Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Oligonucleotide Therapeutics
... at a CAGR of 8.7% over the analysis period 2023-2030. Antisense / RNAI Oligonucleotides Technology, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$4.0 Billion by ... Read More
-
Skin Allergy Therapeutics
... by 2030, growing at a CAGR of 5.3% over the analysis period 2023-2030. The U.S. Market is Estimated at US$472.4 Million While China is Forecast to Grow at 8.3% CAGR The Skin Allergy Therapeutics market ... Read More
-
Hepatitis Therapeutics
... at a CAGR of 3.7% over the analysis period 2023-2030. Hepatitis C Disease Type, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$17.8 Billion by the ... Read More
-
Eye Allergy Therapeutics
... by 2030, growing at a CAGR of 5.4% over the analysis period 2023-2030. Antihistamines, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$2.2 Billion by the ... Read More
-
Systemic Psoriasis Therapeutics
... by 2030, growing at a CAGR of 8.0% over the analysis period 2023-2030. TNF Inhibitors, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$18.5 Billion by ... Read More
-
Alpha 1 Antitrypsin Deficiency Treatment
... is expected to reach US$4.2 Billion by 2030, growing at a CAGR of 9.0% over the analysis period 2023-2030. Augmentation Therapy, one of the segments analyzed in the report, is expected to record a 9.7% ... Read More
-
Sterility Testing
... at a CAGR of 10.8% over the analysis period 2023-2030. Sterility Testing Kits & Reagents, one of the segments analyzed in the report, is expected to record a 12.2% CAGR and reach US$184.9 Million by ... Read More
-
Cntx-4975 Osteoarthritis Drug Pipeline – Market Insights And Forecasts Up to 2032
... trans-capsaicin administered via injection directly to the pain site. This innovative treatment harnesses capsaicin’s natural analgesic properties, aiming to provide rapid, long-lasting, and targeted pain relief. CNTX-4975 further works by targeting the TRPV1 receptor, which ... Read More
-
Global Malignant Pleural Mesothelioma Market (2024 Edition): Analysis By Drug Type (Pemetrexed and Combination, Cisplatin, Carboplatin, Gemcitabine, Vinorelbine, Other Drug Types), By Route of Administration, By Distribution Channel, By Region, By Country: Market Insights and Forecast (2020-2030)
... Forecast (2020-2030) Executive Summary Azoth Analytics has released a research report titled “Global Malignant Pleural Mesothelioma Market (2024 Edition)” which provides a Pemetrexed and Combination analysis of the Global Malignant Pleural Mesothelioma industry in terms ... Read More
-
Intracranial Aneurysms - Market Insights, Competitive Landscape, and Market Forecast - 2030
... America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing cases of chronic disorders and the rising product developmental activities worldwide The ... Read More
-
Metabolomics Reagents - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
... readjusted size of US$ 61.94 million by 2030 with a CAGR of 13.22% during the forecast period 2024-2030. North American market for Metabolomics Reagents was valued at $ 10.10 million in 2023 and will reach ... Read More
-
Scleroderma Diagnostics and Therapeutics
... 2030, growing at a CAGR of 4.1% over the analysis period 2023-2030. Localized Disease, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$1.9 Billion by the ... Read More
-
Thin Film Drug Manufacturing
... 2030, growing at a CAGR of 7.6% over the analysis period 2023-2030. Oral Thin Film, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$9.9 Billion by ... Read More
-
Rheumatology Therapeutics
... CAGR of 3.1% over the analysis period 2023-2030. Disease Modifying Anti-Rheumatic Drugs (DMARDs), one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$51.3 Billion by the end ... Read More
-
United States Next Generation Sequencing Market Report by Products (Instruments, Reagents & Consumables, and Services), Application (Diagnostics, Agriculture and Animal Research, Drug Discovery, Personalized Medicine and Genetic Screening, and Others), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-Molecule Read Time Sequencing, Nanopore Sequencing, and Others), End-Users(Academic and Clinical Research Centers, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, and Others), and Company Analysis 2024-2032
... Semiconductor Sequencing, Single-Molecule Read Time Sequencing, Nanopore Sequencing, and Others), End-Users(Academic and Clinical Research Centers, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, and Others), and Company Analysis 2024-2032 United States Next Generation Sequencing Market Size ... Read More
-
Drug Discovery Services
... at a CAGR of 3.3% over the analysis period 2023-2030. Medicinal Chemistry Services, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$31.6 Billion by the end ... Read More
-
Hyaluronidase
... 8.1% over the analysis period 2023-2030. Animal-Derived Hyaluronidase, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth ... Read More
-
Infectious Disease Therapeutics
... at a CAGR of 7.1% over the analysis period 2023-2030. HIV Disease Therapeutics, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$113.7 Billion by the end ... Read More
-
Myasthenia Gravis Drugs
... by 2030, growing at a CAGR of 6.6% over the analysis period 2023-2030. Drug Treatment, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$2.0 Billion by ... Read More
-
Non-Hodgkin Lymphoma Therapeutics
... by 2030, growing at a CAGR of 7.0% over the analysis period 2023-2030. Immunotherapy, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$10.1 Billion by the ... Read More
-
Plasma Protein Therapeutics
... by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Albumin, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$9.3 Billion by the ... Read More
-
Head and Neck Cancer Therapeutics
... is expected to reach US$4.2 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2023-2030. PD Inhibitors, one of the segments analyzed in the report, is expected to record a 8.4% ... Read More
-
Cervical Cancer Treatment
... at a CAGR of 5.9% over the analysis period 2023-2030. Squamous Cell Carcinoma (SCC) Treatment, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$9.1 Billion by ... Read More
-
Cloud-Based Drug Discovery Platforms
... reach US$10.9 Billion by 2030, growing at a CAGR of 12.7% over the analysis period 2023-2030. Pharmaceutical Vendors End-Use, one of the segments analyzed in the report, is expected to record a 13.0% CAGR and ... Read More
-
Idiopathic Pulmonary Fibrosis
... by 2030, growing at a CAGR of 5.6% over the analysis period 2023-2030. Retail Pharmacies Distribution Channel, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$3.5 ... Read More
Research Assistance
